The popularity of Zibo barbecue, which has gained popularity all over the internet, remains high, while Zibo's "beef" is not just barbecue. According to the official website of the Zibo Municipal Health Commission, the pharmaceutical industry in Zibo has been developing for 80 years. As of 2022, new pharmaceutical enterprises above designated size in the city have achieved a revenue of 38.6 billion yuan, and the economic scale of the pharmaceutical industry has remained the first in the province for many years.

Zibo High tech Zone Biomedical Industry Innovation Park. Image/Zibo High tech Official WeChat

7 biopharmaceutical enterprises are listed companies

On May 10th, the reporter found through enterprise investigation that as of now, there are more than 7000 pharmaceutical related companies and more than 20000 medical device related companies in Zibo City. The biopharmaceutical industry involves fields such as chemical drugs, medical devices, traditional Chinese medicine, and traditional Chinese medicine production.

According to incomplete statistics by reporters, 7 companies, including Xinhua Pharmaceutical, Xinhua Medical, Weiming Pharmaceutical, Yingke Medical, Lanfan Medical, Jincheng Pharmaceutical, and Shandong Pharmaceutical Glass, have already listed on the A-share market.

Among them, Xinhua Pharmaceutical and Xinhua Medical were both born in the anti Japanese base area of Jiaodong in 1943. With these two enterprises as industrial ties, Zibo has gradually formed two advantageous industrial clusters of "chemical pharmaceutical and medical equipment". They are among the top in the production capacity, export volume, and market share of antipyretic and analgesic drugs, antibiotics, and chemical preparations in China, and in medical imaging, sterilization equipment, medical consumables, pharmaceutical equipment Featured areas such as blood equipment have global competitiveness.

In recent years, the biopharmaceutical industry in Zibo High tech Industrial Development Zone has gathered significantly, becoming an important platform for the development of pharmaceuticals in the central region of Shandong. It has gathered leading enterprises such as China Resources 39, Xinhua Pharmaceutical, Xinhua Medical, as well as international enterprises such as Roche and Bayer. In addition, districts and counties such as Linzi and Boshan are also planning and laying out the construction of pharmaceutical industrial parks, further leveraging the advantages of industrial agglomeration.

There are multiple 'firsts' in the field of biomedicine

In February, the official website of the Zibo Municipal People's Government reported that there are more than 180 pharmaceutical industry enterprises in the city. The Zibo High tech Zone has multiple "firsts" in the field of biopharmaceuticals: the largest production and export base for antipyretic and analgesic drugs in Asia, and the production capacity of aspirin and ibuprofen ranks first in the world; We have the world's largest research and development and production enterprise for cephalosporin pharmaceutical intermediates, and are the largest research and development and production base for disinfection and sterilization equipment and radiation therapy equipment in China; The market share of disinfection, endoscopic cleaning, and radiation diagnosis and treatment products remains the first in the country; The development of "specialized, refined, and innovative" characteristic excipients is rapid, with the market share of cyclodextrin series products ranking third globally and first nationwide.

In recent years, Zibo City has successively issued multiple policies to support the development of the biopharmaceutical industry. At the beginning of 2020, Zibo City released the "Overall Plan for the" Four Strong "Industry Climbing Plan in Zibo City (2020-2025)". The key tasks and promotion plan of the pharmaceutical industry in Zibo City involve investment attraction, industry platform building, industrial park planning, and promoting the consistency evaluation of generic drugs.

On February 15th, the "2023 Work Promotion Plan for Zibo New Pharmaceutical Industry Special Class" was issued. On March 13th, the Investment Promotion Bureau of Zibo City announced a key plan for the new pharmaceutical industry, which includes a medical device science and technology innovation service platform, a biopharmaceutical industry park, and downstream extension of the VC industry chain